X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
BOSTON �— A Massachusetts federal judge sided with seven state attorneys general and three from New York counties and remanded back to state courts 10 cases in the multidistrict litigation over average wholesale drug prices. The cases, and the multidistrict litigation, involve whether the companies fraudulently inflated average wholesale prices drug prices, causing government entities to overpay for medical services reimbursed by Medicare. In re: Pharmaceutical Industry Average Wholesale Price Litigation, M.D.L. No. 1456, No. 01-12257 (D. Mass). Although the 10 cases involve numerous defendant companies, three defendant companies initially moved to combine the cases with the multidistrict litigation on the grounds that the court’s unsealing of federal False Claims Act actions against them provided grounds for federal jurisdiction. They argued that 30-day deadline for seeking removal to federal court began when they received notice of a federal qui tam complaint from the U.S. Department of Justice, but the plaintiffs called the removals “groundless and untimely,” according to Judge Patti B. Saris’ order. Officials from the drug companies Abbott Laboratories, Boehringer Ingelheim Corp. and Dey Inc., could not immediately be reached for comment. The cases are returning to Florida, Idaho, Illinois, Kentucky, Mississippi, New York, Ohio and Pennsylvania. On September 12, Judge Saris removed two other cases in the multidistrict action to their federal courts of origin in Montana and Nevada.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at [email protected]

 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.